Natixis’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Buy
67,365
+62,852
+1,393% +$4.13M 0.02% 471
2026
Q1
$321K Buy
+4,513
New +$356K ﹤0.01% 873
2025
Q4
– Sell
-207,425
Closed -$15.6M – 1195
2025
Q3
$15.6M Buy
207,425
+130,435
+169% +$9.73M 0.07% 219
2025
Q2
$5.7M Buy
76,990
+49,602
+181% +$3.45M 0.03% 334
2025
Q1
$2.2M Sell
27,388
-591
-2% -$50.8K 0.01% 411
2024
Q4
$2.19M Buy
+27,979
New +$2.38M 0.01% 459
2024
Q3
– Sell
-25,817
Closed -$2.01M – 1021
2024
Q2
$2.01M Buy
+25,817
New +$2.11M 0.01% 412
2023
Q3
– Sell
-24,488
Closed -$1.99M – 1042
2023
Q2
$1.99M Buy
+24,488
New +$1.95M 0.02% 428

Other funds holding GEHC

Natixis's GEHC Position: Q2 2026 in Review

Natixis increased its GE HealthCare (GEHC) stake by 1,393% in Q2 2026, buying an estimated $4.13M and bringing the position to 67,365 shares worth $4.31M. The position accounts for 0.02% of the portfolio, ranked #471.

Natixis first reported a position in GEHC in Q2 2023 and has held it in 8 quarters since. The position peaked at $15.6M in Q3 2025. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Natixis held 67,365 shares of GE HealthCare worth $4.31M as of Q2 2026.
  • Natixis bought 62,852 GE HealthCare shares in Q2 2026, an estimated $4.13M.
  • GE HealthCare made up 0.02% of Natixis's portfolio in Q2 2026, its #471 holding.
  • Natixis first reported a position in GE HealthCare in Q2 2023 and has held it in 8 quarters since.
  • Natixis's GE HealthCare position peaked at $15.6M in Q3 2025.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.